Andriy Krendyukov

Dr. Andriy Krendyukov, MD, MBA, is a seasoned physician-scientist and pharmaceutical executive with nearly two decades of experience in the development, launch, and commercialization of innovative therapies across oncology, cardiology, endocrinology, neuroscience, and dermatology.

A graduate of the Medical University, Dr. Krendyukov completed his medical training and specialization in 1997, followed by an MBA from the ESSEC & Mannheim Business School in 2013. His early career in Health Care included clinical and research roles at a University Clinic and within emergency medical services.

Driven by a passion for advancing patient care through innovation, Dr. Krendyukov transitioned to the pharmaceutical industry, where he has contributed at both regional and global levels. He frequently lectures on strategy development and pharmaceutical innovation, including engagements at Mannheim Business School’s Consulting Club and major international oncology forums such as ESMO, ESMO Asia.

In recent years, his research has focused on key topics including adaptive trial designs (on-going postdoctoral research at University of Mannheim), strategic frameworks for innovative therapies, healthcare communication pathways, and early access programs. His work has been presented at major scientific conferences and published in peer-reviewed journals.